This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Ingrid Vandenborre
Partner at Skadden, Arps, Slate, Meagher & Flom LLP


Ingrid Vandenborre is the partner in charge of Skadden’s Brussels office. Her practice focuses on EU and international merger control and competition law enforcement. She has consistently been named as a leading practitioner in Who’s Who Legal guides in both competition and life sciences. She was recognized by Global Competition Review on various occasions, including being profiled as a leading antitrust attorney in its 2013 and 2016 “Women in Antitrust” issues, selected for its 2012 “40 Under 40” list and shortlisted in the “Lawyer of the Year — 40 and Under” at the GCR Awards 2013. In 2016, she received the ILO Client Choice Award for the category of EU Competition and Antitrust, awarded by The International Law Office in recognition of individual partners who excel across the full spectrum of client service.

Ms. Vandenborre has significant experience in Article 101 issues in relation to cartel arrangements, as well as vertical and competitive agreements. Her recent experience includes the successful representation of a company involved in the then OFT’s (now CMA) examination of the hotel online booking sector, avoiding formal allegations being raised against the company, and the representation of a generic pharmaceuticals manufacturer in an appeal before the European General Court against the European Commission’s first reverse payment patent settlement decision, having represented the company in the administrative proceedings before the Commission.

Ms. Vandenborre also has successfully assisted companies in obtaining conditional immunity with the European Commission and other competition law agencies in and outside the EU. Recent representations include the immunity and leniency applicants in the EU power cables and car battery recycling cartel investigations, respectively. Ms. Vandenborre also is representing companies in proceedings before the European General Court against European Commission findings of cartel infringements, and is involved in the defense against civil claims arising from these findings.

Ms. Vandenborre has substantial experience advising on Article 102 enforcement issues both at the EU and Member State levels in pharmaceutical and other sectors. She was involved in representing Intel in the Article 102 proceedings before the European Commission.

In addition to her work on Article 101 and 102 enforcement issues, Ms. Vandenborre has substantial merger control experience. Notable recent examples of Ms. Vandenborre’s merger control work include advising:

  • SanDisk Corporation in its $19 billion acquisition by Western Digital Corporation;
  • Pfizer Inc. in its US$160 billion combination with Allergan plc. This ranks as the largest-ever pharmaceutical sector merger of all time;
  • Broadcom Corporation in its US$37 billion acquisition by Avago Technologies Limited;
  • Freescale Semiconductor, Ltd. and a private equity consortium, including The Blackstone Group L.P., The Carlyle Group LP, Permira Funds and TPG Capital, L.P., in Freescale’s US$11.8 billion acquisition by NXP Semiconductors NV;
  • Endo International plc in the US$1.65 billion sale of American Medical Systems Holdings Inc.’s men’s and prostate health business to Boston Scientific Corporation;
  • Archer Daniels Midland Company in its US$3.1 billion acquisition of WILD Flavors GmbH;
  • Valeant Pharmaceuticals International, Inc. in connection with its US$8.7 billion acquisition of Bausch & Lomb Holdings Incorporated;
  • Alfa-Access-Renova (AAR) in the US$56 billion sale of TNK-BP, a joint venture between AAR and BP plc, to Rosneft Oil Company. This was the largest M&A transaction in the world in 2012 and the largest globally for more than three years; and
  • Watson Pharmaceuticals, Inc. in the worldwide antitrust aspects of its US$5.6 billion acquisition of Actavis Group.

Ms. Vandenborre is a graduate of the Catholic University of Leuven in Belgium and completed part of her law studies at Duke University School of Law. She holds an LL.M. degree from the University of Chicago Law School and is an alumna of the Belgian American Educational Foundation.

Agenda Sessions

  • Reviewing Recent Developments in Pricing & Dominance


Speakers at this event